{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:09:55Z","timestamp":1793916595690,"version":"4.8.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p><jats:italic>Candida albicans (C. albicans)<\/jats:italic> is an opportunistic pathogen in immunocompromised individuals and a normal inhabitant of the oral cavity, throat, gastrointestinal tract, and genitourinary system among health populations. Our study focused on identifying new inhibitors capable of binding to the mutant cytochrome P450 family 51 (CYP-51) protein and intended to be effective against resistant <jats:italic>C. albicans<\/jats:italic> infections. The pharmacophore ligand-based model was used for the virtual screening of compound libraries. Molecular docking was performed on Maestro, Schrodinger. ADMET analysis was performed to check drug-likeness properties. Density function theory (DFT) calculations, molecular dynamic (MD) simulation, and free binding energy (MMPBSA) were also calculated. For docking, six compounds were selected from 11,022 hits from PubChem libraries, which showed the best interaction with mutant CYP-51 and were identified by pharmacophore mapping performed with the Pharma IT tool. Each of the six compounds was docked into the active site of the mutant CYP-51 protein. Overall, CP-3 exhibited significant binding affinity (\u221210.70 kcal\/mol) as well as, showed good ADMET characteristics such as drug-likeness, absorption, distribution, metabolism, excretion, and toxicity. The lead compound, CP-3, was further used for MD simulation to observe the dynamic behavior of the complex in the active site of the mutant CYP-51 protein. Computational studies indicated that CP-3 could be a useful antagonist for the mutant protein, CYP-51. This study used computational approaches to identify potential inhibitors of <jats:italic>C. albicans<\/jats:italic> by targeting CYP-51 for antifungal drug development. Further <jats:italic>invitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> studies are needed to evaluate its pharmacokinetic properties and efficacy as a novel antifungal drug.<\/jats:p>","DOI":"10.1371\/journal.pone.0318539","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T18:27:49Z","timestamp":1741112869000},"page":"e0318539","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Identifying novel inhibitors against drug-resistant mutant CYP-51 Candida albicans: A computational study to combat fungal infections"],"prefix":"10.1371","volume":"20","author":[{"given":"Saadia","family":"Jabeen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Umer","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakeel","family":"Waqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Farhana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muharib","family":"Alruwaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir","family":"Alruwaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abualgasim Elgaili","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Mudassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3160-4830","authenticated-orcid":true,"given":"Qurban","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"issue":"36","key":"pone.0318539.ref001","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1016\/j.biomaterials.2007.08.030","article-title":"Cartilage repair using an in vitro generated scaffold-free tissue-engineered construct derived from porcine synovial mesenchymal stem cells","volume":"28","author":"W Ando","year":"2007","journal-title":"Biomaterials"},{"issue":"2","key":"pone.0318539.ref002","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/jof7020079","article-title":"Candida albicans-the virulence factors and clinical manifestations of infection","volume":"7","author":"J Talapko","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"pone.0318539.ref003","first-page":"12","article-title":"Candida albicans el principal hongo pat\u00f3geno oportunista en humanos","volume":"55","author":"IU Macias-Paz","year":"2023","journal-title":"Rev Argent Microbiol"},{"issue":"3","key":"pone.0318539.ref004","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/pathogens11030335","article-title":"Oral cavity and candida albicans: colonisation to the development of infection","volume":"11","author":"M Patel","year":"2022","journal-title":"Pathogens"},{"issue":"8","key":"pone.0318539.ref005","first-page":"1131","article-title":"Determination of minimum inhibitory concentrations of various antifungal agents in clinical isolates of Candida species","volume":"69","author":"H Ejaz","year":"2019","journal-title":"J Pak Med Assoc"},{"issue":"4","key":"pone.0318539.ref006","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/jof4040129","article-title":"Antifungal resistance: specific focus on multidrug resistance in Candida auris and secondary azole resistance in aspergillus fumigatus","volume":"4","author":"S Arikan-Akdagli","year":"2018","journal-title":"J Fungi (Basel)"},{"key":"pone.0318539.ref007","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/myc.12469","article-title":"Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus","volume":"59","author":"SS Gon\u00e7alves","year":"2016","journal-title":"Mycoses"},{"key":"pone.0318539.ref008","doi-asserted-by":"crossref","first-page":"103243","DOI":"10.1016\/j.fgb.2019.103243","article-title":"Candida auris and multidrug resistance: defining the new normal","volume":"131","author":"SR Lockhart","year":"2019","journal-title":"Fungal Genet Biol"},{"key":"pone.0318539.ref009","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cmrp.2017.11.004","article-title":"Candida auris: An emerging multidrug-resistant pathogen of global significance","volume":"7","author":"Z Khan","year":"2017","journal-title":"Curr Med Res Pract"},{"issue":"4","key":"pone.0318539.ref010","doi-asserted-by":"crossref","first-page":"e00334","DOI":"10.1128\/mSphere.00334-18","article-title":"Transcriptome assembly and profiling of candida auris reveals novel insights into biofilm-mediated resistance","volume":"3","author":"R Kean","year":"2018","journal-title":"mSphere"},{"key":"pone.0318539.ref011","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fphar.2014.00202","article-title":"Efflux pump proteins in antifungal resistance","volume":"5","author":"R Prasad","year":"2014","journal-title":"Front Pharmacol"},{"issue":"Supplement_3","key":"pone.0318539.ref012","doi-asserted-by":"crossref","first-page":"S328","DOI":"10.1093\/mmy\/myz012","article-title":"Antifungal drugs: What brings the future?","volume":"57","author":"R Van Daele","year":"2019","journal-title":"Med Mycol"},{"issue":"16","key":"pone.0318539.ref013","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1074\/jbc.M117.778308","article-title":"Structural analyses of Candida albicans sterol 14\u03b1-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis","volume":"292","author":"TY Hargrove","year":"2017","journal-title":"J Biol Chem"},{"issue":"7","key":"pone.0318539.ref014","doi-asserted-by":"crossref","first-page":"e1005775","DOI":"10.1371\/journal.ppat.1005775","article-title":"Sterol biosynthesis and azole tolerance is governed by the opposing actions of SrbA and the CCAAT binding complex","volume":"12","author":"F Gsaller","year":"2016","journal-title":"PLoS Pathog"},{"issue":"1","key":"pone.0318539.ref015","doi-asserted-by":"crossref","first-page":"e01919","DOI":"10.1128\/mBio.01919-15","article-title":"The aspergillus fumigatus damage resistance protein family coordinately regulates ergosterol biosynthesis and azole susceptibility","volume":"7","author":"J Song","year":"2016","journal-title":"mBio"},{"key":"pone.0318539.ref016","doi-asserted-by":"crossref","first-page":"656548","DOI":"10.3389\/fmicb.2021.656548","article-title":"The heat shock transcription factor HsfA is essential for thermotolerance and regulates cell wall integrity in Aspergillus fumigatus","volume":"12","author":"JHTM Fabri","year":"2021","journal-title":"Front Microbiol"},{"issue":"2","key":"pone.0318539.ref017","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1389202917666151116212437","article-title":"Heat shock proteins in dermatophytes: current advances and perspectives","volume":"17","author":"NM Martinez-Rossi","year":"2016","journal-title":"Curr Genomics"},{"issue":"5","key":"pone.0318539.ref018","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/apm.13389","article-title":"Antifungal drug resistance in Candida: a special emphasis on amphotericin B","volume":"132","author":"L Ahmady","year":"2024","journal-title":"APMIS"},{"key":"pone.0318539.ref019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmgm.2015.10.014","article-title":"In silico and in vitro screening to identify structurally diverse non-azole CYP51 inhibitors as potent antifungal agent","volume":"63","author":"A Singh","year":"2016","journal-title":"J Mol Graph Model"},{"key":"pone.0318539.ref020","doi-asserted-by":"crossref","first-page":"845322","DOI":"10.3389\/fmedt.2022.845322","article-title":"Identification of 1, 2, 4-Triazine and its derivatives against LANOSTEROL 14-Demethylase (CYP51) property of Candida albicans: influence on the development of new antifungal therapeutic strategies","volume":"4","author":"AK Verma","year":"2022","journal-title":"Front Med Technol"},{"key":"pone.0318539.ref021","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"J Cheung","year":"2012","journal-title":"J Med Chem"},{"key":"pone.0318539.ref022","doi-asserted-by":"crossref","first-page":"e1298","DOI":"10.1002\/wcms.1298","article-title":"Using PyMOL as a platform for computational drug design","volume":"7","author":"S Yuan","year":"2017","journal-title":"Wiley Interdiscip Rev Comput Mol Sci"},{"issue":"1","key":"pone.0318539.ref023","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13568-024-01762-9","article-title":"Identification of novel natural compounds against CFTR p.Gly628Arg pathogenic variant","volume":"14","author":"MU Khan","year":"2024","journal-title":"AMB Express"},{"issue":"1","key":"pone.0318539.ref024","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13568-024-01664-w","article-title":"In silico analysis of the Val66Met mutation in BDNF protein: implications for psychological stress","volume":"14","author":"MA Shan","year":"2024","journal-title":"AMB Express"},{"issue":"6","key":"pone.0318539.ref025","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1007\/s00210-023-02915-6","article-title":"Hypericum perforatum: a comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative diseases","volume":"397","author":"MV Suryawanshi","year":"2024","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"15","key":"pone.0318539.ref026","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1080\/07391102.2021.1891140","article-title":"Identification of novel allosteric binding sites and multi-targeted allosteric inhibitors of receptor and non-receptor tyrosine kinases using a computational approach","volume":"40","author":"KK Kakarala","year":"2022","journal-title":"J Biomol Struct Dyn"},{"key":"pone.0318539.ref027","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"A Daina","year":"2017","journal-title":"Sci Rep"},{"issue":"9","key":"pone.0318539.ref028","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"DEV Pires","year":"2015","journal-title":"J Med Chem"},{"issue":"10","key":"pone.0318539.ref029","doi-asserted-by":"crossref","first-page":"e0271602","DOI":"10.1371\/journal.pone.0271602","article-title":"In-silico Investigations of quinine and quinidine as potential Inhibitors of AKR1B1 and AKR1B10: Functional and structural characterization","volume":"17","author":"SA Ejaz","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"pone.0318539.ref030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.54112\/bbasr.v2024i1.64","article-title":"An overview of hepatitis c virus and liver cirrhosis in Pakistan","author":"A Ullah","year":"2024","journal-title":"Bull Biol All Sci Res"},{"issue":"6","key":"pone.0318539.ref031","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.hrthm.2024.02.005","article-title":"Predictive value of the PRAETORIAN score for defibrillation test success in patients with subcutaneous ICD: A subanalysis of the PRAETORIAN-DFT trial","volume":"21","author":"RE Knops","year":"2024","journal-title":"Heart Rhythm"},{"issue":"1","key":"pone.0318539.ref032","doi-asserted-by":"crossref","first-page":"85","DOI":"10.54112\/bbasr.v2024i1.85","article-title":"Role of oxidative stress and immune response alterations in asthmatic pregnant females","author":"A Malik","year":"2024","journal-title":"Bull Biol All Sci Res"},{"issue":"4","key":"pone.0318539.ref033","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1039\/C5MB00860C","article-title":"Molecular modeling studies to characterize N-phenylpyrimidin-2-amine selectivity for CDK2 and CDK4 through 3D-QSAR and molecular dynamics simulations","volume":"12","author":"TA Chohan","year":"2016","journal-title":"Mol Biosyst"},{"issue":"1","key":"pone.0318539.ref034","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1038\/s41467-024-48093-8","article-title":"Hyphal Als proteins act as CR3 ligands to promote immune responses against Candida albicans","volume":"15","author":"T Zhou","year":"2024","journal-title":"Nat Commun"},{"key":"pone.0318539.ref035","doi-asserted-by":"crossref","DOI":"10.1515\/9783111434858","volume-title":"Computer-Aided Drug Design: QSAR, Molecular Docking, Virtual Screening, Homology and Pharmacophore Modeling","author":"A Thakur","year":"2024"},{"issue":"1","key":"pone.0318539.ref036","doi-asserted-by":"crossref","first-page":"83","DOI":"10.54112\/bbasr.v2024i1.83","article-title":"Clinical validation of genexpert mtb\/rif assay in the rapid diagnosis of extra pulmonary tuberculosis","author":"M Kashif","year":"2024","journal-title":"Bull Biol All Sci Res"},{"issue":"3","key":"pone.0318539.ref037","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3999\/jscpt.55.3_99","article-title":"Clinical pharmacology strategy for registration in Japan with a case example of posaconazole, a globally approved triazole antifungal drug with broad-spectrum antifungal activity","volume":"55","author":"T IWASA","year":"2024","journal-title":"Rinsho yakuri\/Japanese Journal of Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"pone.0318539.ref038","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1038\/s41598-024-55321-0","article-title":"Targeting human progesterone receptor (PR), through pharmacophore-based screening and molecular simulation revealed potent inhibitors against breast cancer","volume":"14","author":"M Shahab","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0318539.ref039","doi-asserted-by":"crossref","first-page":"84","DOI":"10.54112\/bbasr.v2024i1.84","article-title":"Detection of clinical biomarkers associated with hepato and renal manifestations in covid-19 patients","author":"A Samad","year":"2024","journal-title":"Bull Biol All Sci Res"},{"issue":"13","key":"pone.0318539.ref040","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.3390\/molecules29133086","article-title":"Synthesis and in silico analysis of new polyheterocyclic molecules derived from [1,4]-Benzoxazin-3-one and their inhibitory effect against pancreatic \u03b1-amylase and intestinal \u03b1-glucosidase","volume":"29","author":"M Ellouz","year":"2024","journal-title":"Molecules"},{"issue":"1","key":"pone.0318539.ref041","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13568-024-01742-z","article-title":"Silibinins and curcumin as promising ligands against mutant cystic fibrosis transmembrane regulator protein","volume":"14","author":"A Akram","year":"2024","journal-title":"AMB Express"},{"issue":"1","key":"pone.0318539.ref042","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13568-024-01741-0","article-title":"Antibacterial potential of Propolis: molecular docking, simulation and toxicity analysis","volume":"14","author":"S Islam","year":"2024","journal-title":"AMB Express"},{"issue":"1","key":"pone.0318539.ref043","doi-asserted-by":"crossref","first-page":"95","DOI":"10.54112\/bbasr.v2025i1.95","article-title":"Exploring beclin-1 therapeutic potential in neurodegenerative diseases: focus on multiple sclerosis","author":"A Malik","year":"2025","journal-title":"Bull Biol All Sci Res"},{"issue":"6","key":"pone.0318539.ref044","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3390\/ph17060725","article-title":"Study of the lipophilicity and ADMET parameters of new anticancer diquinothiazines with pharmacophore substituents","volume":"17","author":"D Klimoszek","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"pone.0318539.ref045","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/jox11030007","article-title":"The central role of cytochrome P450 in xenobiotic metabolism-a brief review on a fascinating enzyme family","volume":"11","author":"F Esteves","year":"2021","journal-title":"J Xenobiot"},{"issue":"1","key":"pone.0318539.ref046","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/mutage\/gead032","article-title":"Matrine and Oxymatrine: evaluating the gene mutation potential using in silico tools and the bacterial reverse mutation assay (Ames test)","volume":"39","author":"BC Fischer","year":"2024","journal-title":"Mutagenesis"},{"key":"pone.0318539.ref047","first-page":"5391296","article-title":"Antioxidant properties of curcumin analogues to inhibit thermal degradation of low\u2010density polyethylene: Experimental and DFT study","author":"AM Al-Asadi","year":"2022","journal-title":"J Chem"},{"key":"pone.0318539.ref048","doi-asserted-by":"crossref","first-page":"100412","DOI":"10.1016\/j.chphi.2023.100412","article-title":"Integrative study of phytochemicals for anti-fibroid agent: A perspective on protein networks, molecular docking, ADMET, simulation, DFT and bioactivity","volume":"8","author":"CB Olowosoke","year":"2024","journal-title":"Chem Phys Impact"},{"key":"pone.0318539.ref049","first-page":"5031577","article-title":"Fluconazole\u2010like compounds as potential antifungal agents: QSAR, molecular docking, and molecular dynamics simulation","author":"F Salehi","year":"2022","journal-title":"J Chem"},{"issue":"11","key":"pone.0318539.ref050","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.3390\/cells10113014","article-title":"In silico designing of a multitope vaccine against rhizopus microsporus with potential activity against other mucormycosis causing fungi","volume":"10","author":"MA Soltan","year":"2021","journal-title":"Cells"},{"key":"pone.0318539.ref051","first-page":"775","article-title":"In silico and in vitro analyses to investigate the effects of vitamin C on VEGF protein","volume":"19","author":"A Sakhawat","year":"2024","journal-title":"J Taibah Univ Med Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0318539","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T18:28:08Z","timestamp":1741112888000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0318539"}},"subtitle":[],"editor":[{"given":"Ahmed A.","family":"Al-Karmalawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":51,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0318539","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]}}}